Similar articles

• Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells.

  Huettl P, Gerhardt GA, Browning MD, Masserano JM. Huettl P, et al. J Pharmacol Exp Ther. 1991 May;257(2):567-74. J Pharmacol Exp Ther. 1991. PMID: 1674528
• [Current developments in the pharmacology of dopaminergic receptors (I)].

  Nechifor M, Lucaci L. Nechifor M, et al. Rev Med Chir Soc Med Nat Iasi. 1989 Jan-Mar;93(1):143-4. Rev Med Chir Soc Med Nat Iasi. 1989. PMID: 2573121 Review. Romanian. No abstract available.
• The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs.

  Memo M, Missale C, Pizzi M, Spano PF. Memo M, et al. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:458A-459A. doi: 10.1097/00002826-199201001-00239. Clin Neuropharmacol. 1992. PMID: 1354049 No abstract available.
• Dopamine D2 receptor binding properties of [3H]U-86170, a dopamine receptor agonist.

  Lahti RA, Evans DL, Figur LM, Carrigan KJ, Moon MW, Hsi RS. Lahti RA, et al. Eur J Pharmacol. 1991 Sep 17;202(2):289-91. doi: 10.1016/0014-2999(91)90308-d. Eur J Pharmacol. 1991. PMID: 1687034
• [Current developments in the pharmacology of dopaminergic receptors (II)].

  Nechifor M. Nechifor M. Rev Med Chir Soc Med Nat Iasi. 1989 Apr-Jun;93(2):393-4. Rev Med Chir Soc Med Nat Iasi. 1989. PMID: 2573123 Review. Romanian. No abstract available.